Leonteq Securities AG’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Leonteq Securities AG's RMD Position: Q2 2026 in Review
Leonteq Securities AG increased its ResMed (RMD) stake by 31% in Q2 2026, buying an estimated $99.7K and bringing the position to 2,038 shares worth $397K. The position accounts for 0.01% of the portfolio, ranked #449.
Leonteq Securities AG first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Leonteq Securities AG held 2,038 shares of ResMed worth $397K as of Q2 2026.
- Leonteq Securities AG bought 481 ResMed shares in Q2 2026, an estimated $99.7K.
- ResMed made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #449 holding.
- Leonteq Securities AG first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.